Oral Versus Intravenous Antibiotic Prophylaxis Before Obstetric and Gynecological Procedures

Recruiting

• Conditions: Site Infection
• Interventions: Drug: Cephradin

• Registration Number: NCT06255652
• Lead Sponsor: Sohag University

Brief Summary

Oral versus intravenous antimicrobial prophylaxis for the prevention of surgical site infection for elective cesarean section and gynacological procedures

Detailed Description

the aim of the current study is to compare the efficacy of prophylactic intravenous (cephradine) and oral antibiotic (cephradine) for the prevention of surgical site infection in the elective obctetric and gynecological procedures

Study Timeline

• Study Start: 2023-10-01
• Status Verified: 2024-02
• Study First Submitted: 2024-02-05
• Study First Submitted QC: 2024-02-05
• Last Update Submitted: 2024-02-05
• Study First Posted: 2024-02-13
• Last Update Posted: 2024-02-13
• Primary Completion: 2024-07-31
• Study Completion: 2024-07-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 1

Inclusion Criteria

• Cesarean section Gynaecological procedure Exclusion Criteria Immunocompromised patient

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Obstetrician and gynaecological procedures	Cephradin	Patients for obstetricians

Primary Outcome Measures

Name	Time	Method
proportion of patients with any SSI within 30 days after surgery	July 2024	July 2024

Trial Locations

Locations (1)

Sohag university hospital; 🇪🇬 Sohag, Egypt